Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

ribavirin amidine

Known as: TARIBAVIRIN, 1-beta-D-ribofuranosyl-1,2,4-triazole-3-carboxamidine, viramidine 
An orally available prodrug of ribavirin, a synthetic nucleoside analog of ribofuranose with activity against a wide range of viruses, especially the… Expand
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2010
Review
2010
The standard treatment of HCV infection with pegylated interferon-alpha2a or -alpha2b and ribavirin is effective in <50% of HCV… Expand
  • figure 1
Review
2008
Review
2008
Abstract The currently circulating H3N2 and H1N1 subtypes of influenza A virus cause a transient, febrile upper respiratory… Expand
  • figure 1
  • figure 3
Review
2007
Review
2007
Liver disease secondary to chronic hepatitis C virus (HCV) infection is an important cause of morbidity and mortality in dialysis… Expand
  • figure 1
  • table 2
Highly Cited
2007
Highly Cited
2007
BACKGROUND/AIMS Pegylated interferon plus ribavirin can cause dose-limiting anemia. Taribavirin, a ribavirin prodrug, has shown a… Expand
Review
2007
Review
2007
Anemia is a common side effect that begins soon after the initiation of peginterferon/ribavirin in the treatment of hepatitis C… Expand
  • figure 1
  • table 1
  • figure 2
  • figure 3
Review
2006
Review
2006
Abstract: Chronic infection with hepatitis C virus (HCV) can progress to cirrhosis, hepatocellular carcinoma, and end‐stage liver… Expand
Highly Cited
2005
Highly Cited
2005
Viramidine, the 3-carboxamidine derivative of ribavirin, was effective against a spectrum of influenza A (H1N1, H3N2 and H5N1… Expand
Review
2004
Review
2004
  • G. Foster
  • Seminars in liver disease
  • 2004
  • Corpus ID: 40079519
Conventional interferon (IFN) alfa has been used for many years in the treatment of chronic hepatitis C. However, few patients… Expand
Highly Cited
2003
Highly Cited
2003
Ribavirin, part of the current first line combination therapy for the treatment of chronic hepatitis C, may cause haemolytic… Expand
  • figure 1
  • table 1
  • table 2
  • table 5
  • table 6
Review
2002
Review
2002
  • J. Watson
  • Current opinion in investigational drugs
  • 2002
  • Corpus ID: 28790122
Ribavirin, in combination with interferons, has proved clinically useful for the treatment of hepatitis C virus (HCV) infection… Expand